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1. Introduction
Photodynamic Therapy (PDT) is a technique for the
treatment of cancer and other pathological diseases
based on the photoinduced cytotoxicity on the target
cells [1]. In the presence of a photosensitizer, dys-
plastic cells or microorganisms will be destroyed
when light of a certain wavelength mediates local cy-
totoxic effects caused by reactive oxygen species,
especially singlet oxygen [2]. The choice of PDT is
determined by many factors, like cost, instrumenta-
tion, the patient and the location of the lesions. The
topical PDT of superficial tissues with 5-aminolevuli-
nic acid, a precursor of an important photosensitizer
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Photodynamic Therapy (PDT) with 5-aminolevulinic acid
(ALA) is known to be limited for applications in tu-
mours of large volume mainly due to the limited penetra-
tion of topical photosensitization. The results show that
micro-holes created using a femtosecond laser before
PDT significantly increased the depth of PDT effect in
the healthy tissue. The combination of ultrashort laser
ablation technique with PDT showed an important scien-
tific breakthrough related to transportation and delivery
of drugs into the deeper regions of the tissue.
A representative image of a rat skin with the micro-dril-
lings.
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used in PDT treatment (protoporphyrin IX or
PpIX), has been achieving promising clinical results
[3, 4]. A major advantage of topical PDT is the lack
of systemic skin photosensitivity, a situation that ob-
liges the avoidance of sun exposure by the patient.
5-ALA is a precursor of heme formed by 5-ALA
synthase from glycine and succinyl-CoA, the rate-
limiting step of the heme biosynthesis [5]. Once this
step is bypassed by exogenous administration of 5-
ALA, porphyrins and heme accumulate mainly in
malignant or abnormal tissue, where metabolic activ-
ity is different.
In dermatology PDT is widely used for the treat-
ment of premalignant lesion and basal cell carcino-
ma (BCC) [6–8]. The technique has some limitations
in cases of injuries that are too thick, due to limited
delivery of medication. A limiting factor of ALA-
PDT is the drug penetration depth for the treatment
of bulk tumoral lesions [9].
The drug delivery technology to deeper regions
in biological systems is well-studied and of consider-
able interest for medical applications [10]. Many
authors have investigated alternatives to improve
drug delivery and increase the effects of PDT [11].
Experiments using nude mice, porcine skin and
other biological targets have shown that silicon mi-
cro-needle puncture could reduce application time
and the ALA dose required to induce high levels of
the photosensitizer protoporphyrin IX in skin [12,
13]. The combination of iron-chelating agents in-
creases and/or accelerates the accumulation of PpIX
induced by the prodrugs ALA (aminolevulinic acid),
MAL (methyl aminolevulinate), and HAL (hexyl
aminolevulinate) in squamous carcinoma (A431),
and glioma (U-87 MG) cells [14]. Clinical investiga-
tion of the novel iron-chelating agent, CP94, to en-
hance topical photodynamic therapy of nodular
BCC also has been studied [15]. Other works have
investigated the light fractionation effects. Vijlder
et al. [16] observed that it significantly improves in
the response of superficial BCC and Brujin et al.
[17] demonstrated that light fractionation, with a
long dark interval, significantly increases the re-
sponse to ALA-PDT in pre-clinical models and in
non-melanoma skin cancer.
One good way of improving the drug delivery is
using a laser as a “photonic syringe”, a non-invasive
system which can cause less pain to the patient. For
this we used a technique known as laser ablation.
This technique involves tissue removal by laser
beam. Some author reported the importance and ef-
ficiency of ablative fractional laser for drug delivery
enhancement [18, 19] and as pre-treatment in PTD
[20, 21].
A precise tissue removal with minimal collateral
thermo-mechanical damage is necessary in many la-
ser-surgical applications, including neurosurgery,
dentistry and cardiology [13, 22]. Laser ablation of
biological tissue, in the ultra-short pulses regime, is a
technique employed due to its characteristic light-tis-
sue interaction, resulting in a precise ablation techni-
que [22–29], and avoidance of thermal damage in
the surroundings [26]. It has been applied to the pro-
cessing of soft and hard biological tissues, such as
tooth [25, 26], bone [26, 28, 29], skin and liver [9].
The laser ablation of soft tissues shows interesting
mechanisms of laser-tissue interaction [9, 22–24, 27].
The hypothesis tested in this paper was that the
delivery of the drug to deeper regions of the tissue
could be enhanced by a mechanical mechanism,
where transversal micro-channels are produced in
the region where the drug will be applied. Thus, the
micro-channels assist in the delivery of drugs which
have difficulty in penetrating the skin, as is the case
for compounds that have large proteins. The drug
cream reaches the deep regions of the tissue through
these micro-channels and, consequently, results in
deeper photosensitization. Few studies have dis-
cussed new laser ablation parameters to improve the
drug (ALA) penetration and damage depth in bio-
logical tissues. The combination of ultrashort laser
ablation technique with PDT is an important scienti-
fic breakthrough related to transportation and deliv-
ery of drugs into the deeper regions of the tissue.
2. Experimental
2.1 Animal procedure
Fifteen male Wistar rats of approximately 300 g each
were used in this study. The study was approved by
the Local Institutional Ethics Committee. Animals
were anaesthetized with an 0.08 ml/100 g ketamine
solution (Ketamine Agener 10%, Agener Unia˜o,
Brazil), associated with xylazine 0.04 ml/100 g, an an-
algesic, sedative and muscle relaxant (Xylasine 2%,
Coopazine, Schering-Plough, United States) intra-
muscular injection. The trichotomy was performed
and the skin surface exposed for irradiation. The rats
were positioned and moved in a linear translation
stage (x – y – z). A study was made of the optimal
parameters for laser ablation in the skin.
2.2 Laser ablation and PDT parameters
A Ti: Sapphire femtosecond (Libra-S, Coherent,
Palo Alto, CA, USA) laser emitting pulses of ap-
proximately 70 fs, emission centered at a wavelength
of 801 nm and operating at a pulse repetition rate of
100–1000 Hz was used in this study to produce the
micro-channels.
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After laser ablation, the surfaces of the rat skin
were photosensitized with cream containing 20%
Aminolevulinic acid (PDTPharma, Cravinhos-SP,
Brazil). After 2 hours of occlusion, the skin was irra-
diated in a fluence of between 50 and 100 J/cm2 at
an intensity of 50 mW/cm2. A 630 nm diode laser,
Eagle Heron (Quantum Tech, Sa˜o Carlos-SP, Brazil),
was used as a PDT light source and an optical fiber
of 300 mm diameters with coupled micro-lenses was
used to obtain a uniform irradiation profile.
The pieces obtained were fixed in 10% formalin
for 24 h. After this, they went through routine la-
boratory procedures until they were set in paraffin,
and 5-mm-thick sections were obtained and stained
with hematoxylin and eosin (HE) for histological
analysis. The image analysis was done using a Zeiss1
microscope, model Axioskop 2 plus, and the image
captured with an AxioCam Mrc digital camera and
using a 100 objective. A semi-quantitative analysis
was performed for the following histological aspects:
edema, necrosis, inflammatory infiltrate and hemor-
rhagic foci.
In the first part of this paper we performed a
comparative study using the laser operating in differ-
ent regimes of average power and irradiation time.
An experimental setup was developed in order to
find the appropriate parameters for a tissue ablation
free of charring and other secondary damage. Wister
rats were placed in an x – y – z translator and
micro-channels were made in different areas of
the skin, approximately 7.0 mm  5.0 mm spaced
0.25 mm, using an average power of 200 mW (Fig-
ure 1). The average power values were determined
using a power meter (Coherent LM10, USA). After
this, the skins were used to quantify the change in
depth of tissue damage in PDT as a function of the
micro-channels obtained by laser ablation. The verti-
cal micro-channels were produced perpendicularly
to the skin surface. The beam waist on the surface of
the skin was approximately 50 mm.
The animals used in this study were separated in
to four different groups containing three animals
each: a control group that represents only micro-dril-
ling (CG); micro-drilling + PDT 50 J/cm2 (MP50J);
micro-drilling + PDT at 100 J/cm2 (MP100J); PDT
50 J/cm2 (P50J); PDT 100 J/cm2 (P100J).
The conditions for the PpIX production were
standardized to achieve the drug-light interval
(DLI), and determined based on a previous study
where the authors evaluated the production of PpIX
by fluorescence spectroscopy as a function of time.
With this technique we can non-invasively investi-
gate the superficial presence of the PpIX in real
time. The DLI was determined based on the time
necessary for the generated PpIX to reach the pla-
teau and before the clearance becomes more impor-
tant than the production, i.e., at the decrease of
fluorescence emission. After 2 hours of occlusion
with 100 mg ALA cream 20% (w/w), a maximum of
PpIX was observed using fluorescence spectroscopy.
The animals were kept alive for exactly 30 hours
to allow the establishment of necrosis; they were
killed with anesthesia overdose and their skin was
removed. The tissue damage was macroscopically
evaluated, and samples were prepared for histologi-
cal analysis (HE staining method). The aspect of the
necrotic tissue and the depth of tissue damage (the
measurement of the damage length from the irra-
diated surface to the limit between necrotic and
healthy tissues) were the main analyzed characteris-
tics. The histopathological analyses were based on
the qualitative observation of the slides on an optical
microscope.
3. Results and discussion
Figure 2 shows profile pictures of damage in rat skin
after femtosecond laser irradiation, in accordance
with the details of Figure 1.
The samples were irradiated with a femtosecond
laser, using pulse energy of 52 mJ to 110 mJ, repeti-
tion rate of 1 kHz, and irradiation time of 5 seconds.
After this, a study of histological slides of the tissue
was made, and it was observed that the energy den-
sity applied on the tissue was not sufficient to induce
an ablation, because a significant change in morphol-
ogy of the tissue was observed (Figure 2A).
This change is associated with tissue damage
caused by thermal laser-tissue interaction, resulting
in the destruction of tissue cells, becoming more evi-
dent by the purple color of the image. In Figure 2B
the energy density applied on the fabric was twice
that in Figure 2A and, thus, it was possible to obtain
an “optical breakdown”, leading to a tissue ablation.
Figure 1 A representative image of a rat skin with the mi-
cro-drillings.
J. Biophotonics 7, No. 8 (2014) 633
FULL
ARTICLE
# 2014 by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimwww.biophotonics-journal.org
The parameters used have caused a major change
in the peripheral tissue (Figure 2A and B). Around
the cavity, regions with strong staining in purple and
pink, associated with altered thermal tissue, were ob-
served, indicating cell destruction (Figure 2B).
The animals of the group treated with PDT and
previous micro-drilling showed a pattern of lesions
with the presence of hemorrhagic foci (hypodermis
and dermis) and inflammatory infiltrate, edema and
areas of necrosis (Figure 3A and B).
In the Figure 3, panels A and B, a greater inten-
sity of MP100J was used (panel B) in comparison
with MP50J (panel A). In the MP100J observed le-
sions distributed throughout the epidermis (necro-
sis), the papillary dermis, the hypodermis (among
adipocytes) and muscle tissue, whereas group MP50J
showed evidence in the dermis, hypodermis and
muscle fibers. Two animals of the Group MP50J pre-
sented little dermal inflammatory infiltrate and hy-
podermic without bleeding.
Finally, the next figure shows the histological re-
sults of the skins of healthy animals treated with
PDT, without micro-drilling (Figure 4A and B).
Weaker effects in the dermis and hypodermis
were observed (edema and necrosis), with few he-
morrhagic foci and inflammatory infiltration. Both
animals of Group PDT50 (Figure 4A) as the Group
PDT100 (Figure 4B) demonstrated a few spots of he-
morrhage and inflammatory infiltration in the papil-
lary layer of the dermis, compared to the Group
MP50J and MP100J (Figure 3, panels A and B).
After photodynamic therapy occurs, the intensive
damage in the epithelial cell and inflammatory infil-
trate is finally observed, thus leading to necrosis of
the irradiated tissue [30].
The histological analysis of this experiment
shows that the micro-holes created using a femtose-
cond laser before PDT increase significantly the
depth of your effect to healthy tissue. Skin treated
with PDT after micro-drilling presented hemorrhagic
foci in muscle tissue and hypodermis, abundantly in
the group MP100J and moderately in MP50J (this
was especially evident in the hypodermis), suggest-
ing a greater depth in delivering the drug (cream
containing ALA) in tissue and consequently a high-
er photochemical reaction, demonstrating a greater
Figure 2 Histological images of damage profile in healthy
rat tissue after irradiation with a femtosecond laser with
52 mJ and 5 s (Panel A), and 110 mJ and 5 s (Panel B).
Figure 3 Photomicrographs of healthy rat tissue in the micro-drilling + PDT group (MP). Panel A: MP50J; panel B:
MP100J. Smaller lesions intensity were observed in panel A. Dermis (D); edema among adipocytes (E); hemorrhagic foci
in the hypodermis and between fibers muscle (*); perivascular inflammatory infiltrate in the hypodermis (II); muscle fibers
(M); hypoderm (H). 100. H.E.
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inflammatory process in the different layers of the
skin.
In the hypodermis region there was also found
abundant inflammatory infiltrate in all groups, with
a higher intensity in the groups with micro-drilling.
The papillary dermis inflammatory infiltrates were
also seen in all groups, mainly in the group MP100J,
in which edema in the papillary dermis was ob-
served.
Topical drug delivery is essential in dermatology
and the efficacy of topically applied drugs is crucially
dependent on their ability to penetrate the outer-
most skin barrier of stratum corneum (SC) and epi-
dermis. Some studies have been developed in this
context. Hædersdal et al. [31] observed that, from
the creating of deep channels into skin through
which direct penetration of drugs can occur, AFR
appears to not only bypass the SC barrier, but to
provide substantial delivery of MAL into deep der-
mis, in vivo. Lee et al. [32] also showed a greater en-
hancement effect on skin permeation of 5-FU, when
the SC layer in the skin was partly ablated by an er-
bium :YAG (Er :YAG) laser. Penetration enhance-
ment of two topical 5-aminolaevulinic acid formula-
tions for photodynamic therapy by Er :YAG laser
ablation of the SC was observed by [19]. Different
laser systems have been used to pre-treat tissue prior
to topically applied ALA, as the fractionated CO2
laser [18]. Another work compares the 5-year lesion
response rates of superficial BCC treated with topi-
cal aminolaevulinic acid (ALA)-PDT using a single
illumination (75 J/cm2 delivered 4 hours after 20%
ALA cream application) vs. ALA-PDT using a 2-
fold illumination scheme (20 and 80 J/cm2 delivered
4 and 6 hours after 20% ALA cream application, re-
spectively). The complete response rate was signifi-
cantly greater following the 2-fold illumination than
the single illumination [16].
Fractional ablative lasers are commercially avail-
able as CO2 lasers (10.600 nm) and Er :YAG lasers
(2.940 nm) [16–21, 31, 33]. Tissue absorption at these
wavelengths is dominated by water. Deep tissue
holes are created by a dynamic laser tissue interac-
tion in which water absorption coefficients and pulse
widths are responsible for the formation of (micro-
scopic treatments zones) MTZ with different dimen-
sions of ablation and thermal coagulation zones
(TCZ) [31]. Potentially, bleeding through the laser
holes may decrease drug uptake after AFR. On the
other hand, a thick residual TCZ may inhibit the dif-
fusion of some drugs from the laser hole into sur-
rounding dermis [31]. Appropriate laser parameters
are essential in order to obtain a desired penetration
depth of the epidermis without destruction of viable
tissue that may impair the formation of PpIX [21].
Femtosecond lasers are presented as great candi-
dates for this purpose, because of the mechanisms
involved in the ablative processes in biological tissue
with minimal thermal damage [9, 22–29]. Further-
more, they do not form an epidermal necrotic zone,
a potential obstacle for drug penetration, which is
usually seen in erbium glass–based fractional lasers
[20].
Other techniques that enhance drug penetration
of the skin include micro-needling and microderm-
abrasion [12, 13, 33]. Micro-needling offers a simple
method to increase the superficial penetration of
ALA. Donnelly et al. [12] evaluated micro-needle
mediated intradermal delivery of 5-ALA, which en-
hanced ALA delivery to superficial regions of ex-
Figure 4 Photomicrographs of healthy rat tissue in the PDT group (PDT). Panel A: PDT50J; panel B: PDT100J. The
arrows show an area with mild inflammatory infiltrate in hypodermis (H) and between muscle fibers (M). Dermis (D);
100. H.E.
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cised porcine skin, but not to deeper skin layers.
There are important differences between micro-nee-
dle puncture and AFR. AFR removes tissue, leaving
an open channel into which topically applied drugs
can migrate. AFR is hemostatic, such that there is
little or no bleeding or fluid loss through the laser
ablated holes, which could impede drug uptake [31].
Togsverd-Bo et al. [21] demonstrated that the
PDT with MAL is effective for thin actinic keratoses
(AKs) in field-cancerized skin. The authors showed
that Ablative fractional laser resurfacing (AFXL)-
PDT serves as an intensified treatment modality
with significantly better efficacy compared with con-
ventional PDT. They concluded that the AFXL-PDT
represents a promising and intensified treatment
modality for AK with a strong clinical potential to
improve future PDT of especially thick lesions in
field-cancerized skin. YOO et al. [20] in their pilot
study reported the potential of the combination of
ablative (CO2) fractional laser and MAL-PDT for
synergistic effects in recalcitrant periungual warts.
As for the results, a mean clearance of 100% was
achieved in 36 (90%) warts, with a shorter incuba-
tion time, lower treatment number, no recurrences,
and no severe side effects. Therefore, this pilot study
supports the examination of the potential of the
combination of ablative CO2 fractional laser and
MAL-PDT in recalcitrant periungual warts for syner-
gistic effects.
4. Conclusion
In this paper we concluded that the combination of
an ultra-short laser ablation technique with PDT,
aiming to use the laser as a tool to assist in the deliv-
ery of drugs into the deeper regions of biological
systems, is a good alternative to other forms of deliv-
ery. We observed that the tissues previously irra-
diated with a femtosecond laser indirectly showed
that the drug reached the deepest regions and made
a significant process of acute inflammation in the tis-
sues after PDT. However, we believe that further
studies should be conducted to analyse the PpIX in
micro-perforated tissues, since these results repre-
sent an important scientific breakthrough related to
transportation and delivery of drugs into the deeper
regions of the tissue.
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